Status:
UNKNOWN
Prevalence Study of Amyloidosis in Patients With Surgery of Suspect Bilateral Carpal Tunnel (AMYLYONCARP)
Lead Sponsor:
Centre Hospitalier Saint Joseph Saint Luc de Lyon
Conditions:
Carpal Tunnel Syndrome Bilateral
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the prevalence of amyloidosis in population of patient affected by suspect bilateral carpal tunnel with indication of surgery
Eligibility Criteria
Inclusion
- bilateral carpal tunnel with indication of surgery and judged suspect:
- age of 50 years old and more
- non-traumatic or undetermined neuropathic etiology or cardiac history (atrial arrhythmia or Heart Failure or cardiac stimulation) or family history of hereditary amyloidosis or monoclonal gammopathy
Exclusion
- patient with diagnosis of amyloidosis
- traumatic bilateral carpal tunnel or linked to rheumatoid arthritis
Key Trial Info
Start Date :
May 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04890119
Start Date
May 17 2021
End Date
September 1 2024
Last Update
May 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Saint Joseph Saint Luc
Lyon, France, 69007